274. 骨形成不全症 Osteogenesis Imperfecta Clinical trials / Disease details

臨床試験数 : 87 / 薬物数 : 103 - (DrugBank : 20) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 76

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2004-005275-42-IT (EUCTR)	21/03/2005	23/01/2008	Study on the effect of r-hGH in combination with bisphosphonate treatment on bone metabolism in Oste ...	Study on the effect of r-hGH in combination with bisphosphonate treatment on bone metabolism in Oste ...	Osteogenesis Imperfecta MedDRA version: 6.1;Level: SOC;Classification code 10010331	Trade Name: GENOTROPIN1TBF 5,3MG (16UI) INN or Proposed INN: Somatropin Trade Name: NERIXIAINFUS IV ...	AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA	NULL	Not Recruiting			Female: yes Male: yes			Italy
2	NCT00001305 (ClinicalTrials.gov)	November 5, 1991	3/11/1999	Growth Hormone Therapy in Osteogenesis Imperfecta	Studies of Growth Deficiency and Growth HormoneTreatment in Children With Osteogenesis Imperfecta Ty ...	Osteogenesis Imperfecta	Drug: Humatrope	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	NULL	Completed	3 Years	16 Years	All	42	Phase 3	United States

First Previous1Next Last